nach oben

Erschienen in:

01.08.2003 | Original

HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery

verfasst von: Wolfgang Oczenski, Herbert Krenn, Ruth Jilch, Herbert Watzka, Ferdinand Waldenberger, Ursula Köller, Sylvia Schwarz, Robert D. Fitzgerald

Erschienen in: Intensive Care Medicine | Ausgabe 8/2003

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study investigated the predictive value of a decrease in monocyte HLA-DR expression as an early marker for postoperative SIRS and septic complications. We hypothesized that decreased HLA-DR levels in the first 24 h after cardiac surgery is not related to postoperative SIRS/sepsis. We also compared HLA-DR levels of patients with postoperative complications to those with an uncomplicated course.

Design and setting

Prospective observational study in a tertiary care postoperative intensive care unit.

Patients

Eighty five consecutive patients undergoing cardiac surgery.

Measurements and results

Expression of HLA-DR on monocytes was analyzed by flow cytometry using a new quantitative and well standardized technique. Arterial blood samples were collected before induction of anesthesia, immediately after admission to the ICU, and on the first postoperative day. Postoperative HLA-DR expression was significantly decreased in all patients. There were no significant differences in HLA-DR expression during the first 24 h after surgery in patients with uncomplicated course and those developing SIRS or septic complications.

Conclusions

In patients undergoing cardiac surgery the monitoring of pre- and immediate postoperative HLA-DR levels during the first 24 h does not help to predict increased risk for postoperative SIRS/sepsis or infectious complications.

Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL (1987) Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 139:3802–3807PubMed

Edwards JA, Durant BM, Jones DB, Evans PR, Smith JL (1985) Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. J Immunol 137:490–497

Levacher M, Tallet S, Dazza M, Dournon E, Rouveix B, Pocidalo J (1990) T activation marker evaluation in ARC patients treated with AZT: comparison with CD4⁺ lymphocyte count in non-progressors and progressors towards AIDS. Clin Exp Immunol 81:177–182PubMed

Terstappen LWMM, Hollander Z, Meiners H, Loken M (1990) Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol 48:138–148PubMed

Cheadle WG (1993) The human leucocyte antigens and their relationship to infection. Am J Surg 165 [Suppl]:75S–81S

Wakefield CH, Carey PD, Foulds S, Monson JRT, Guillou PJ (1993) Changes in major histocompatibility complex class II expression in monocytes and T-cells of patients developing infection after surgery. Br J Surg 80:205–209PubMed

Van den Berk J, Oldenburger R, Van den Berg A, Klompmaker I, Mesander G, Van Son W, Van der Bij W, Slooff M, Hauwthe T (1997) Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation 63:1846–1848PubMed

Asadullah K, Woiciechowsky C, Döcke WD, Liebenthal C, Wauer H, Kox W, Volk HD, Vogel S, Von Baehr R (1995) Immunodepression following neurosurgical procedures. Crit Care Med 23:1976–1983

Ditschkowski M, Kreutzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid E, Obertacke U, Hirche H, Schade U, Grosse-Wilde H (1999) HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Annals of Surgery 229:246–254CrossRefPubMed

10.

Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CGM, Cohen Tervaert JW (2000) Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 26:883–892

11.

Kress HG, Scheidewig C, Schmidt H, Silber R (1999) Reduced incidence of postoperative infection after intravenous administration of an immunoglobin A- and immunoglobin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27:1281–1287PubMed

12.

Hummel M, Doecke WD, Friedel N, Von Baehr R, Hetzer R, Volk HD (1994) Monitoring of the cellular immune system in patients with biventricular assist devices awaiting cardiac transplantation. Clin Transpl 8:59–66PubMed

13.

Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, Haverich A, Schlag G, Borst HG (1996) Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61:1714–1720PubMed

14.

McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM (1995) Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 75:724–733PubMed

15.

Allen ML, Peters MJ, Goldman A, Elliot M, James I, Callard R, Klein NJ (2002) Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 30:1140–1145PubMed

16.

Centers for Disease Control and Prevention (1994) Guideline for prevention of nosocomial pneumonia. Respir Care 39:1191–1236PubMed

17.

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874PubMed

18.

Bone RC, Sibbald WJ, Sprung CL (1998) The ACCP-SCCM Consensus Conference on sepsis and organ failure. Chest 101:1481–1483

19.

Rinder CS, Mathew JP, Rinder HM, Tracey JB, Davis E, Smith BR (1997) Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med 129:592–602PubMed

20.

Hiesmayr MJ, Spittler A, Lassnigg A, Berger R, Laufer G, Kocher A, Artemiou O, Boltz-Nitulescu G, Roth E (1999) Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol 115:315–323CrossRefPubMed

21.

Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Müller JM, Döcke WD Kox WJ (1996) Monocyte deactivation–rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22:474–481

Titel: HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery
verfasst von: Wolfgang Oczenski
Herbert Krenn
Ruth Jilch
Herbert Watzka
Ferdinand Waldenberger
Ursula Köller
Sylvia Schwarz
Robert D. Fitzgerald
Publikationsdatum: 01.08.2003
Verlag: Springer-Verlag
Erschienen in: Intensive Care Medicine / Ausgabe 8/2003
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-1826-8

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery